curasan AG scouts for sales partners for ATR®
Supporting wound healing and tissue regeneration through the extraction of autologous platelet-mediator-concentrate (PMC) – high patient compatibility using autologous blood – No need for centrifuges and external laboratoriesKleinostheim, Germany – curasan AG, listed in the General Standard of the Frankfurt Stock Exchange (ISIN: DE 000 549 453 8), has commenced with the pre-marketing activities for the launch of its new product ATR® (Advanced Tissue Regeneration).
ATR® is a standardised system for extracting growth factors, which support wound healing and tissue regeneration. The areas of application include severe skin damage such as ulcers, large-area burns, skin transplantations, cartilage and cell culture or chronic wounds. Furthermore, the product can have a favourable impact on the wound healing process for the optimised regeneration of bones and mucous membranes in plastic surgery, in oral and maxillofacial surgery and implantology.
“ATR® is an attractive proposition for various specialised enterprises on account of its wide range of applications. Since a marketable product is now available, we can actively pursue negotiations with potential sales partners with immediate effect”, explains Hans Dieter Rössler, CEO of curasan AG.
Initially, the activities are aimed at Germany and the European market. However, in the medium term curasan AG anticipates enormous potential for ATR®, above all, in the US market.
With the help of ATR®, autologous platelet-mediator-concentrate (PMC) is extracted from the patient’s own blood, which ensures a high degree of compatibility. PMC supplies the important growth factors for wound healing and tissue regeneration, which can then be brought directly in the wound area. ATR® is a single use device that requires neither machines nor external laboratories; hence, there are no investment costs and no costs incurred in the services provided by third parties.
The ATR® system contains everything that is needed to extract the concentrate either in the doctor’s practice or in the operating room.
Background information about curasan AG:
Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading firms in the field of regenerative medicine especially in bone and tissue regeneration. In addition to the synthetic Cerasorb® bone substitution and regeneration material, the company has developed a future-oriented product pipeline. The goal during the next few years is to have further medical products ready for market rollout via well-positioned contractual partners in various market segments.
Press Contact:
curasan AG
Andrea Weidner
Lindigstrasse 4
63801 Kleinostheim
Germany
Tel. +49 (0)6027 40 900-51
Fax +49 (0)6027 40 900-39
andrea.weidner@curasan.de
www.curasan.de
fr financial relations gmbh
Jörn Gleisner
Gutleutstrasse 75
60329 Frankfurt/Main
Germany
Tel. +49 (0)69 95 90 83 20
Fax +49 (0)69 95 90 83 99
j.gleisner@finanical-relations.de
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release curasan AG scouts for sales partners for ATR® here
News-ID: 139576 • Views: …
More Releases from curasan AG
curasan AG: Dental Business Unit acquired as of June 1
Kleinostheim, Germany, June 6, 2013 – curasan AG, Germany, has acquired a large part of the “Oral Regenerative Medicine” division of Riemser Pharma GmbH, Germany, effective June 1, 2013.
curasan AG now owns the marketing and distribution rights for the products covered by the contract and is assuming the sales structures, including the na-tional and international customer base.
As a result of this change, curasan has immediate access to the dental market…
curasan AG now sells bone regeneration material in injectable form
Kleinostheim, 05.12.2012 – curasan AG, listed on the General Standard (ISIN: DE 000 549 453 8), has introduced its new bone regeneration material CERASORB® Ortho Paste to the German and European markets at the beginning of December.
CERASORB® Ortho Paste is comprised of fine granules of the proven, fully resorbable, synthetic material CERASORB® M Ortho suspended in a hyaluronic acid hydrogel-matrix. The paste-like product has the advantage that it is…
curasan AG commences operations in the European market with the appointment of a …
Kleinostheim, 15.02.2012 – curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8), created a new post on 1st February 2012 in relation to the active expansion of its European sales network in the fields of Orthopaedics and trauma surgery. Mr. Lee McCann BSc Business Administration (North West University of Applied Science, London, U.K.), will be operating as the organisation’s International Sales Director for Orthobiologics with immediate…
curasan AG: Novel bone regeneration material approved for sale in Europe
Kleinostheim, Germany – curasan AG, which is listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received European approval for a novel synthetic bone regeneration material.
Osseolive® is a bioactive, poly-crystalline calcium-alkali-phosphate ceramic, which has a stimulating effect on bone formation as well as on bone mineralisation.
“With Osseolive® emerging from our well-stocked development pipeline, we now have an ideal extension to our tricalcium-phosphate…
More Releases for ATR®
General Aviation Market is Going to Boom with ATR Aircraft, Textron, Airbus
Advance Market Analytics published a new research publication on “General Aviation Market Insights, to 2026” with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the General Aviation market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Antenna Transducer and Radome (ATR) Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Antenna Transducer and Radome (ATR) market analysis, which studies the Dynamic Light Scattering (DLS) Analysis's industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “ Global Antenna Transducer and Radome (ATR) Market Growth 2020-2025 ” Research Report categorizes the global Dynamic Light Scattering (DLS) Analysis market by key players, product type, applications…
ATR: High volatility as success factor for trading.
Recently, a relevant article has been published to the issue of the average true range (ATR) and a simple moving average (SMA) trading strategy in the International Journal of Recent Scientific Research (IJRSR), by Dr. Ulrich R. Deinwallner. Dr. Ulrich R. Deinwallner has published so far several articles regarding relevant research to investment strategies for U.S. stock markets. According to the findings in his current article, excess returns…
Chemical Process Simulators Market 2017- AmsterCHEM, WinSim Inc., ATR, Amit Katy …
Apex Research, recently published a detailed market research study focused on the "Chemical Process Simulators Market" across the global, regional and country level. The report provides 360° analysis of "Chemical Process Simulators Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Chemical Process Simulators industry, and estimates the future trend of Chemical…
Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia and Rad3 Related Prot …
Market Research Hub Report titled 'SerineThreonine Protein Kinase ATR Pipeline Review, H1 2017'; Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 2.7.11.1) pipeline Target constitutes close to 12 molecules. Out of which approximately 11 molecules are developed by companies and remaining by the universities/institutes.
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1177492
Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or…
Global Antenna, Transducer and Radome (ATR) Market Professional Survey Report 20 …
Summary
This report studies Antenna, Transducer and Radome (ATR) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Commscope Inc.
Hongke Microwave Communication Co., Ltd
Ethertronics Inc.
Scelectron
Antenna World Inc.
L-3 Communications Holding Inc.
Thales…